Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors
NCT07587996
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Solid Tumors (Any Localization)
Interventions
DRUG:
radionuclide therapy with ¹⁷⁷Lu-CTR-FAPI
Sponsor
Lanzhou University Second Hospital